BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1382561)

  • 21. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma.
    Finger LR; Kagan J; Christopher G; Kurtzberg J; Hershfield MS; Nowell PC; Croce CM
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5039-43. PubMed ID: 2740341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of minimal residual disease by PCR in childhood T-cell acute lymphoblastic leukemia with TAL1 gene rearrangement: a preliminary report.
    Kikuchi A; Hanada R; Yamamoto K; Hayashi Y
    Med Pediatr Oncol; 1999 Feb; 32(2):148. PubMed ID: 9950206
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombination hotspot associated factors specifically recognize novel target sequences at the site of interchromosomal rearrangements in T-ALL patients with t(8;14)(q24;q11) and t(1;14)(p32;q11).
    Kasai M; Aoki K; Matsuo Y; Minowada J; Maziarz RT; Strominger JL
    Int Immunol; 1994 Jul; 6(7):1017-25. PubMed ID: 7947454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
    Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
    J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
    Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
    Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.
    Wang J; Jani-Sait SN; Escalon EA; Carroll AJ; de Jong PJ; Kirsch IR; Aplan PD
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3497-502. PubMed ID: 10737801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
    Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
    Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
    Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
    Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
    Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
    Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
    Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
    Ono Y; Fukuhara N; Yoshie O
    Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).
    Hansen-Hagge TE; Schäfer M; Kiyoi H; Morris SW; Whitlock JA; Koch P; Bohlmann I; Mahotka C; Bartram CR; Janssen JW
    Leukemia; 2002 Nov; 16(11):2205-12. PubMed ID: 12399963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
    Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
    J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia.
    van der Burg M; Poulsen TS; Hunger SP; Beverloo HB; Smit EM; Vang-Nielsen K; Langerak AW; van Dongen JJ
    Leukemia; 2004 May; 18(5):895-908. PubMed ID: 15042105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
    Cho HS; Kim MK; Bae YK
    Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
    Janssen JW; Ludwig WD; Sterry W; Bartram CR
    Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.